You could be a candidate for Eversense if:
You're taking insulin injections or on a non-automated insulin pump
You have commercial health insurance or are on Medicare
Commercial Insurance
300+ million people have insurance that covers the Eversense E3 CGM System. We offer a free benefits investigation for those who pre-qualify.
Medicare
The Eversense E3 CGM System is covered by Medicare for insulin patients who meet the Medicare coverage criteria. If you're on insulin you might benefit from Eversense.
Learn more and see if you're eligible for Eversense under Medicare.
Eversense PASS Program
Through the Payment Assistance and Simple Savings (PASS) program, you may be eligible for a $99 offer for your sensor and transmitter and subsequent sensors.*
Frequently Asked Questions
The out-of-pocket cost for Eversense E3 is approximately $2,900 (estimated for sensor, transmitter and procedure). However, 300+ million people have insurance that covers the Eversense E3 CGM System - we encourage you to complete our pre-qualification form to confirm your insurance coverage.
Through the Payment Assistance and Simple Savings (PASS) program, you may be eligible for a $99 offer for your sensor and transmitter and subsequent sensors.*
* Offer does not apply to the insertion and removal procedures. The Eversense PASS Program has limitations on eligibility. See website (bit.ly/EversensePass) for more details. Ascensia Diabetes Care reserves the right to change or terminate this program at any time without notice. The program benefit is capped per transaction. There may be instances in which patient out-of-pocket costs exceed what is detailed in the offer.
An Eversense Expert can help! After your eligibility is confirmed, we’ll answer any questions you may have, assist you in locating an Eversense Inserter nearby, and determine the cost based on your insurance. We’ll submit the claim to your insurance provider and work directly with your health care provider and a distribution partner to order your Eversense CGM.
We will remain in contact with you via email every step of the way.
Yes, insurance may cover both the product (sensor and transmitter) and the insertion and removal procedures. However every situation is different, so we recommend you get in touch via our pre-qualify form and an Eversense Expert can confirm what insurance covers for you and what out-of-pocket costs you may have.
Download our discussion guide and bring it to your next appointment and talk to your doctor about how Eversense may be a better fit for your diabetes management plan. We will work with you and your health care provider to manage your insurance claim.
Our pre-qualification form will ask you a few questions about your diabetes type, therapy and your current insurance provider - this will allow us to tell you what your insurance may cover for Eversense. Our Eversense Expert will then get in touch with you to confirm your details and submit the claim to your insurance provider and work directly with your health care provider and a distribution partner to order your Eversense CGM.
See why people are choosing
Eversense.
Learn more about the experiences of Eversense users whose lives were changed after switching to a long-term CGM.
Want to see if you
qualify?
Our short quiz will ask about your insurance coverage, your insulin usage, and what benefits you’re looking for in a CGM.
If you’re ready, click below and let’s see if Eversense is right for you.
* Offer does not apply to the insertion and removal procedures. The Eversense PASS Program has limitations on eligibility. See website (bit.ly/EversensePass) for more details. Ascensia Diabetes Care reserves the right to change or terminate this program at any time without notice. The program benefit is capped per transaction. There may be instances in which patient out-of-pocket costs exceed what is detailed in the offer.
The Eversense® E3 Continuous Glucose Monitoring (CGM) System is indicated for continually measuring glucose levels for up to 180 days in persons with diabetes age 18 and older. The system is indicated for use to replace fingerstick blood glucose (BG) measurements for diabetes treatment decisions. Fingerstick BG measurements are still required for calibration primarily one time a day after day 21, and when symptoms do not match CGM information or when taking medications of the tetracycline class. The sensor insertion and removal procedures are performed by a health care provider. The Eversense E3 CGM System is a prescription device; patients should talk to their health care provider to learn more. For safety information click here.
Eversense, Eversense E3 Continuous Glucose Monitoring and the Eversense logo are trademarks of Senseonics, Incorporated. Ascensia, and the Ascensia Diabetes Care logo are trademarks and/or registered trademarks of Ascensia Diabetes Care Holdings AG. All other trademarks are properties of their respective owners and are used solely for informative purposes. No relationship or endorsement should be inferred or implied.
Apple Watch® is a product of Apple, Inc., and may be separately purchased from an authorized Apple retailer. Apple Watch is not included with the Eversense CGM System. Android is a trademark of Google LLC.
PP-SENS-E3-US-0059